64Cu-SAR-bisPSMA

Copper-64-labeled SAR-bisPSMA · Clarity Pharmaceuticals Ltd

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for 64Cu-SAR-bisPSMA, covering 2022-03-18 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: 64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer [Phase 3]

See pricing